Clinical Trial Update: BR101801 in Adult Patients With Advanced Hematologic Malignancies(Phase I) [Phase 1]

View source ↗

Summary

Phase I clinical trial update for BR101801 in adults with advanced hematologic malignancies; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma
• Chronic Lymphocytic Leukemia
• Diffuse Large B-cell Lymphoma
• Follicular Lymphoma
• Marginal Zone Lymphoma
• Peripheral T-cell Lymphoma
• Small Lymphocytic Lymphoma
• Waldenström Macroglobulinemia

Drugs mentioned

• BR101801

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Diffuse Large B Cell Lymphoma, Follicular Lymphoma | Phase 1 | Status: COMPLETED